Drug Shortage Report for JAMP-RIZATRIPTAN IR
| Report ID | 144901 |
| Drug Identification Number | 02429233 |
| Brand name | JAMP-RIZATRIPTAN IR |
| Common or Proper name | Rizatriptan benzoate tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RIZATRIPTAN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1 x 6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-07-23 |
| Estimated end date | 2022-12-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-12-21 | French | Compare |
| v3 | 2021-12-21 | English | Compare |
| v2 | 2021-08-31 | French | Compare |
| v1 | 2021-08-31 | English | Compare |
Showing 1 to 4 of 4